Janie Goddard
Janie Goddard's purchase track record
How the stock did after each of Janie Goddard's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/15/2025 | ULBI | $10K | +21.9% | +14.8% | +10.8% |
| 6/13/2025 | ULBI | $12K | -11.5% | -25.7% | +14.2% |
| 6/7/2024 | ULBI | $15K | -15.3% | -30.5% | +13.9% |
| 9/11/2023 | ULBI | $16K | -30.4% | -4.8% | +14.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Methode Electronics shares fall, investor day scheduled. Recent coverage placed Methode Electronics among stocks that saw sharp declines and listed it as a company to avoid. The negative sentiment contributed to a drop in the share price. The company announced an investor day at the New York Stock Exchange on December 17, 2026, offering an opportunity for management to discuss its outlook.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
ESS Tech (GWH) Featured in Weekly Industrials Movers Lists. ESS Tech (GWH) appeared in multiple recent lists of notable movers within the industrials sector. These reports highlight the stock's recent price activity and gaps during trading sessions. The company remains a subject of interest in market tracking tools, reflecting its role in the broader industrial market movements this week.
Transaction History
| ULBI | ▲ Buy | Open Market | 1,739 | $10K | 12/15/2025 | View on chart |
| MEI | ▲ Buy | Grant | 264 | $2K | 8/1/2025 | View on chart |
| ULBI | ▲ Buy | Open Market | 1,548 | $12K | 6/13/2025 | View on chart |
| MEI | ▲ Buy | Grant | 491 | $3K | 5/2/2025 | View on chart |
| MEI | ▲ Buy | Grant | 286 | $3K | 1/31/2025 | View on chart |
| MEI | ▲ Buy | Grant | 353 | $3K | 11/1/2024 | View on chart |
| MEI | ▲ Buy | Grant | 245 | $3K | 7/26/2024 | View on chart |
| MEI | ▲ Buy | Grant | 14,170 | $140K | 6/13/2024 | View on chart |
| ULBI | ▲ Buy | Open Market | 1,397 | $15K | 6/7/2024 | View on chart |
| MEI | ▲ Buy | Grant | 95 | $1K | 4/26/2024 | View on chart |
| MEI | ▲ Buy | Grant | 54 | $1K | 1/26/2024 | View on chart |
| MEI | ▲ Buy | Grant | 50 | $1K | 10/27/2023 | View on chart |
| ULBI | ▲ Buy | Open Market | 1,500 | $16K | 9/11/2023 | View on chart |
| MEI | ▲ Buy | Grant | 35 | $1K | 7/28/2023 | View on chart |
| MEI | ▲ Buy | Grant | 4,201 | $140K | 7/5/2023 | View on chart |
| MEI | ▲ Buy | Grant | 13 | $549 | 4/28/2023 | View on chart |
| MEI | ▲ Buy | Grant | 12 | $548 | 1/27/2023 | View on chart |
| MEI | ▲ Buy | Grant | 13 | $546 | 10/28/2022 | View on chart |
| MEI | ▲ Buy | Grant | 13 | $544 | 7/29/2022 | View on chart |
| MEI | ▲ Buy | Grant | 3,885 | $140K | 7/7/2022 | View on chart |
| GWH | ▼ Sell | Other | 50,000 | — | 10/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Ultralife Upgraded to Neutral on Backlog and Product Progress
Ultralife Corporation received an upgrade to a Neutral rating, driven by its current backlog and progress in commercializing new products. This analyst action suggests improved confidence in the company's operational outlook. The stock is currently trading within its 52-week range, with recent technical signals indicating interaction with key support levels.
Ultralife Upgraded to Neutral on Backlog and Product Progress. Ultralife Corporation received an upgrade to a Neutral rating, driven by its current backlog and progress in commercializing new products. This analyst action suggests improved confidence in the company's operational outlook. The stock is currently trading within its 52-week range, with recent technical signals indicating interaction with key support levels.